ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Jubilant Spins Off Nonpharma Business

by Jean-François Tremblay
July 19, 2010 | APPEARED IN VOLUME 88, ISSUE 29

India’s Jubilant Organosys will split itself into two listed units on the Indian National Stock Exchange. One entity, named Jubilant Life Sciences, will focus on pyridine derivatives and the custom manufacturing of pharmaceutical ingredients. The other unit, to be named Jubilant Industries, will consist of Jubilant’s crop protection and specialty polymers businesses. Jubilant says the split will help its businesses operate more efficiently than is currently possible, particularly in terms of how they raise capital.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment